Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Israel Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20052
20074
20082
20101
20113
20121
20132
20141
20152
20165
20172
20183
20192
20205
20214
20221
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated10
Active, not recruiting7
Withdrawn5
Recruiting5
Unknown status5
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Celgene4
Hadassah Medical Organization3
Takeda3
Tel-Aviv Sourasky Medical Center3
AbbVie2
European Organisation for Research and Treatment of Cancer - EORTC2
Janssen Research & Development, LLC2
Minovia Therapeutics Ltd.2
Sheba Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes52
Leukemia, Myeloid, Acute19
Anemia8
Lymphoma, Non-Hodgkin6
Myeloproliferative Disorders6
Hematologic Neoplasms5
Leukemia, Myelomonocytic, Chronic5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Anemia, Refractory, with Excess of Blasts4
Hodgkin Disease4

Trials

Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.